- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06496074
Heart Rate Variation in Females Predicts Tilt Test Results
September 24, 2024 updated by: Carlos Eduardo Batista de Lima, MD, PhD, Federal University of Piaui
Sex-Specific Heart Rate Variations in Predicting Outcomes of Head-Up Tilt Tests in Syncope Patients
Head-up tilt test (HUTT) is widely used to evaluate patients with unexplained syncope, but data on clinical predictors of HUTT results are limited.
The investigators aim to evaluate heart rate (HR) variations and blood pressure (BP) changes associated with the HUTT results and the difference according to the gender.
For this, a cross-sectional study will be performed with patients attended with unexplained syncope submitted to HUTT (70-degree angle), from January/2011 to April/2015.
The investigators will analyze BP changes and Receiver-Operating Characteristics (ROC) curves for the maximum interval in HR variation from the first minute to tenth minute (delta-HR 10) after tilting.
The significance level will be considered at 5%.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
The protocols for the HUTT are passive or prolonged inclination protocol [40 minutes] and mixed protocol: passive phase [first 20 minutes] plus nitrate-provoked phase [last 20 minutes], with the use of 1.25 mg sublingual isosorbide dinitrate.
Blood pressure (BP) measurements will be obtained manually with the Welch Allyn® DS44-11BR, Durashock sphygmomanometer and heart rate (HR) data will be obtained continuously by cardiac monitoring in a conventional 12-lead ECG-PC TEB® surface electrocardiogram with automatic measurements certified by Brazilian National Standards/International Electrotechnical Commission (NBR/IEC) 60601-2-51 and registration number with Brazilian Health Regulatory Agency (ANVISA): 10265690026.
All patients will be submitted to 10 minutes of rest in the supine position at zero degree before the tilt phase of the HUTT.
During this period, HR and systolic (SBP) and diastolic (DBP) measurements will be obtained every 2 minutes.
After this phase, the table is tilted at an angle of 70° with measurement of SBP / DBP and HR every minute.
Patients older than 60 years are routinely investigated for carotid sinus hypersensitivity by carotid sinus massage during the passive phase of the HUTT.
The exam is considered positive according to the criteria defined in guidelines.
The variables analyzed are: age; sex; symptoms prior to examination including syncope, near-syncope and others including dizziness, palpitations and suspected dysautonomia; The maximum heart rate (HR) interval variations present from the rest phase up to the first minute (HR Delta 1min) and from the first minute up to the tenth minute (HR Delta 10min) in tilt phase are documented.
The interval changes in systolic and diastolic blood pressure measurements are obtained from the last measurement of the rest phase up to the first minute in tilt phase.
For statistical analysis, the Chi-square test will be used to verify the dependence or independence of variables considered by evaluating the association between qualitative variables.
The t-Student test will be used to evaluate the differences between the means of the two groups.
The Mann-Whitney test (Wilcoxon rank-sum test) will be used to compare two unpaired groups verifying whether or not they belong to the same population and whose requirements for applying the t-student test are not met.
For the definition of the cutoff points of variations in HR, the ROC curves will be constructed for the HR delta 1 min and HR delta 10 min variables, evaluating the performance of these parameters and analyzing the sensitivity and specificity for their correlation with the positivity in the HUTT.
Through the logistic regression model, the probability curves will be constructed for the HUTT positivity for the parameters of HR delta 1 min and HR delta 10 min and for the non-positivity in the HUTT in relation to the BP variation up to the second minute of the examination.
The significance level will be considered at 5%.
Statistical analysis will be performed using the Statistical Package for the Social Sciences (SPSS, version 18.0 for Windows).
Study Type
Observational
Enrollment (Estimated)
149
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Piauí
-
Teresina, Piauí, Brazil, 64048-350
- Carlos Eduardo Batista de Lima
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients ≥ 18 years old, male or female, with the presence of the inclusion criteria and without exclusion criteria, attended with a history of syncope submitted to head-up tilt test, between January 2011 and April 2015, by the Federal University of Piaui, Brazil in co-participation with the private sector including the Clinicardio and the ITACOR Hospital, specialized centers for diagnosis and treatment of the heart disease.
Description
Inclusion Criteria:
- Patients ≥ 18 years old
- Patients attended with a history of syncope submitted to head-up tilt test
Exclusion Criteria:
- Patients < 18 years old
- Patients without a history of true syncope
- Patients who did not submit to head-up tilt test
- Withdrawal of the consent form at the request of the patient or guardian
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Positive head-up tilt test
Patients who underwent to head-up tilt test (HUTT) and met criteria for positive exam according to the defined in guidelines.
|
Two protocols for the head-up tilt test (HUTT) are used in our center and in the collaborating centers: (1) passive or prolonged inclination protocol [40 minutes], (2) mixed protocol: passive phase [first 20 minutes] plus nitrate-provoked phase [last 20 minutes], with the use of 1.25 mg sublingual isosorbide dinitrate.
All patients are submitted to 10 minutes of rest in the supine position at zero degree before the tilt phase of the HUTT.
During this period, HR and systolic (SBP) and diastolic (DBP) measurements are obtained every 2 minutes.
After this phase, the table is tilted at an angle of 70° with measurement of SBP / DBP and HR every minute.
Patients older than 60 years are routinely investigated for carotid sinus hypersensitivity by carotid sinus massage during the passive phase of the HUTT.
The exam is considered positive according to the criteria defined in guidelines.
|
|
Negative head-up tilt test
Patients who underwent to head-up tilt test (HUTT) and did not met criteria for positive exam according to the defined in guidelines.
|
Two protocols for the head-up tilt test (HUTT) are used in our center and in the collaborating centers: (1) passive or prolonged inclination protocol [40 minutes], (2) mixed protocol: passive phase [first 20 minutes] plus nitrate-provoked phase [last 20 minutes], with the use of 1.25 mg sublingual isosorbide dinitrate.
All patients are submitted to 10 minutes of rest in the supine position at zero degree before the tilt phase of the HUTT.
During this period, HR and systolic (SBP) and diastolic (DBP) measurements are obtained every 2 minutes.
After this phase, the table is tilted at an angle of 70° with measurement of SBP / DBP and HR every minute.
Patients older than 60 years are routinely investigated for carotid sinus hypersensitivity by carotid sinus massage during the passive phase of the HUTT.
The exam is considered positive according to the criteria defined in guidelines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Positive diagnostic correlation
Time Frame: 30 days
|
Positive diagnostic correlation of the data obtained in group 1 (positive head-up tilt test) in relation to group 2 (negative head-up tilt test).
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure variation in the head-up tilt test
Time Frame: 30 days
|
Accuracy, sensitivity, and specificity of blood pressure values as predictors of outcome in the head-up tilt test
|
30 days
|
|
Heart rate variation in the head-up tilt test
Time Frame: 30 days
|
Accuracy, sensitivity, and specificity of heart rate values as predictors of outcome in the head-up tilt test
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Carlos Eduardo Batista Lima, MD, PhD, Federal University of Piaui
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 2, 2024
Primary Completion (Actual)
September 2, 2024
Study Completion (Estimated)
July 2, 2025
Study Registration Dates
First Submitted
July 3, 2024
First Submitted That Met QC Criteria
July 3, 2024
First Posted (Actual)
July 11, 2024
Study Record Updates
Last Update Posted (Actual)
September 26, 2024
Last Update Submitted That Met QC Criteria
September 24, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FUPiaui_tilt_test
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
I have no plan to share individual patient data with other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Syncope, Vasovagal
-
Tanvir HospitalEnrolling by invitationVasovagal Syncope (VVS)India
-
University of CalgaryRecruitingSyncope | Vasovagal Syncope (VVS)Canada
-
David B. De LurgioBiosense Webster, Inc.CompletedNeurocardiogenic Syncope | Vasovagal SyncopeUnited States
-
University of CalgaryRecruiting
-
Dr. Bob SheldonVanderbilt UniversityActive, not recruitingVasovagal SyncopeUnited States, Canada, Poland
-
University of CalgaryCardiac Arrhythmia Network of CanadaCompleted
-
Hospices Civils de LyonNot yet recruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingVasovagal Syncope (VVS)Netherlands
-
Istituto Auxologico ItalianoRecruitingSyncope, Vasovagal, Neurally-MediatedItaly, France, Netherlands, Spain, Sweden
Clinical Trials on Head-up Tilt Test
-
University of Sao Paulo General HospitalFleuryNot yet recruitingAmyloid Neuropathies | Autonomic Nervous System DiseaseBrazil
-
University of California, San DiegoWithdrawnParkinson Disease | Cognitive Impairment | Cognitive Change | Cognitive Decline | Orthostatic Hypertension
-
Radboud University Medical CenterLeiden University Medical Center; Michael J. Fox Foundation for Parkinson's...Active, not recruitingParkinson Disease | ParkinsonismNetherlands
-
Military Institute of Aviation MedicineNalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy... and other collaboratorsCompletedIschemia | Hypoxia | Orthostatic HypotensionPoland
-
Chinese PLA General HospitalActive, not recruitingMRI | Neuroplasticity | Microgravity | Repeatable Battery for the Assessment of Neuropsychological StatusChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingCritically Ill | Mechanical Ventilation | Early Mobilization | Diaphragm Dysfunction
-
University of CalgaryRecruiting
-
University of AlbertaCompleted
-
University Hospital, LilleCompletedHypovolemia | Somatic PainFrance
-
DLR German Aerospace CenterUniversity of Cologne; University Hospital, Umeå; Forschungszentrum JuelichCompletedIntracranial HypertensionGermany